Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study

Abstract Purpose Cisplatin-based combination chemotherapy is considered standard treatment for advanced/recurrent cervical carcinoma; however, the majority of patients do not respond. This study was undertaken to identify the prognostic factors and develop a model predictive of (non-) response to ch...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Gynecologic oncology 2010-01, Vol.116 (1), p.44-49
Hauptverfasser:	Moore, David H, Tian, Chunqiao, Monk, Bradley J, Long, Harry J, Omura, George A, Bloss, Jeffrey D
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Antineoplastic Combined Chemotherapy Protocols - therapeutic use Bleomycin - administration & dosage Cervical cancer Cisplatin Cisplatin - administration & dosage Disease-Free Survival Female Hematology, Oncology and Palliative Medicine Humans Ifosfamide - administration & dosage Logistic Models Middle Aged Models, Statistical Multivariate Analysis Obstetrics and Gynecology Paclitaxel - administration & dosage Predictive Value of Tests Retrospective Studies Topotecan - administration & dosage Treatment Outcome Tumor response, Prognostic factor Uterine Cervical Neoplasms - drug therapy Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!